Drug Shortage Report for APO-METHYLPHENIDATE ER
Report ID | 137581 |
Drug Identification Number | 02452758 |
Brand name | APO-METHYLPHENIDATE ER |
Common or Proper name | METHYLPHENIDATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 27MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-04-12 |
Estimated end date | 2021-09-29 |
Actual end date | 2021-09-21 |
Shortage status | Resolved |
Updated date | 2021-09-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2021-09-27 | English | Compare |
v12 | 2021-09-10 | French | Compare |
v11 | 2021-09-10 | English | Compare |
v10 | 2021-09-01 | French | Compare |
v9 | 2021-09-01 | English | Compare |
v8 | 2021-08-16 | French | Compare |
v7 | 2021-08-16 | English | Compare |
v6 | 2021-07-22 | French | Compare |
v5 | 2021-07-22 | English | Compare |
v4 | 2021-04-21 | French | Compare |
v3 | 2021-04-21 | English | Compare |
v2 | 2021-04-16 | French | Compare |
v1 | 2021-04-16 | English | Compare |
Showing 1 to 13 of 13